Close Menu
Home › Molecular Profiling of Cancer Patients Uncovers Combination Treatments in I-PREDICT Study

Molecular Profiling of Cancer Patients Uncovers Combination Treatments in I-PREDICT Study

Apr 22, 2019

NEW YORK (GenomeWeb) – Clinical trials in oncology may benefit from relying on personalized combination therapies rather than matching patients to monotherapies, according to a new analysis from the Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) team.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Jul
23
Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

What's Popular?

In Cancer

  1. Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

    Premium

  2. Wake Forest Researchers Learn From Patient Data in Offering Precision Oncology Broadly

    Premium

  3. ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

    Premium

  4. Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

  5. Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.